Jyske Realkredit A/S
5.2.2026 10:55:24 CET | Globenewswire | Press release
Jyske Realkredit A/S publishes Supplement no 1 to Base prospectus dated 27 June 2025
Jyske Realkredit A/S publishes Supplement no 1 to Base prospectus dated 27 June 2025
To Nasdaq Copenhagen A/S 05 February 2026
Announcement no. 12/2026
Jyske Realkredit A/S publishes Supplement no 1 to Base prospectus dated 27 June 2025
Jyske Realkredit hereby publish Supplement no. 1 to Base prospectus dated 27 June 2025 for covered bonds, mortgage bonds and bonds issued pursuant to Section 15 of the Danish Mortage-Credit Loans and Mortgage-Credit Bonds etc. Act.
Jyske Realkredit’s Base Prospectus dated 27 June 2025 and Supplements are available for download in Danish and English on Jyske Realkredit’s website www.jyskerealkredit.dk. In the event of discrepancies between the original Danish text and the English translation, the Danish text shall prevail. Jyske Realkredit’s Supplement no 1 is also enclosed this announcement.
For more information, please contact:
- Head of Rating and IR, Christian Bech-Ravn on telephone (+45) 89 89 92 25
- Legal Counsel Berit Fredberg on telephone (+45) 89 89 79 64
Yours sincerely,
Jyske Realkredit
Please observe that the Danish version of this announcement prevails.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Trifork Group AG26.8.2026 17:43:32 CEST | Press release
51/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
Scandinavian Tobacco Group A/S26.8.2026 17:20:00 CEST | Press release
Scandinavian Tobacco Group: Interim Report 1 January – 30 June 2026: Progressing with Focus2030 and Full Year 2026 Guidance maintained
Aegon Ltd.26.8.2026 15:50:00 CEST | Press release
Aegon has filed Shareholder Circular for proposed US redomiciliation
ODDIFACT26.8.2026 15:27:59 CEST | Press release
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
Værdipapirfonden Independent Invest II26.8.2026 15:03:40 CEST | Pressemeddelelse
Fusion af afdelinger i Værdipapirfonden Independent Invest II
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom